AcademyHealth National Health Policy Conference Session: If the NIH Funds the Research, Should There Be a “Government Discount”

Emphasizing economics and practicality, this panel will explore several key questions:

• What is the “value” to taxpayers for NIH-funded research that translates into early-stage life-sciences products, and should such funding impact pricing?
• How does the COVID pandemic, rapid vaccine development process, and related funding infusion impact economic and societal viewpoints on the core question?
• Should NIH funding impact future changes to the patent, licensing, or regulatory pathways?